SABS
SAB Biotherapeutics Inc
3.20$
+0.2%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 51.6% | 60.9% | 61.9% | 43.4% | 70.2% | 53.8% | 58.5% | |
| 35.2% | 22.3% | 40.9% | 29.6% | 67.4% | 20.1% | 6.1% | |
| 35.2% | 22.3% | 40.9% | 29.6% | 67.4% | 47.0% | 55.9% | |
| 15.7% | 36.4% | 9.9% | 10.9% | 0.0% | 0.1% | 0.5% | |
| 48.4% | 39.1% | 38.1% | 45.7% | – | – | – | |
| 112.8% | 31.0% | 52.5% | 39.0% | 31.7% | 41.2% | 12.3% | |
| 25.7% | 19.6% | 32.6% | 29.5% | 12.9% | 18.1% | 6.2% | |
| 10.8% | 2.9% | 3.8% | 2.7% | 2.2% | 1.8% | 0.6% | |
| 12.1% | 13.1% | 5.5% | 7.2% | 1.1% | 3.8% | 1.8% | |
| 0.3% | 0.3% | – | 1.1% | – | – | – | |
| -12.8% | 69.0% | 47.5% | 61.0% | 68.3% | 58.8% | 87.7% | |
| -178.3% | -21.2% | -35.9% | -94.0% | -107.3% | -281.0% | -64.2% | |
| 24.1% | 4.8% | 3.4% | 8.5% | 6.6% | 21.0% | 35.5% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.